Trials / Completed
CompletedNCT01979887
Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 75 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
This is an exploratory study to evaluate endpoints used to characterize participants with and without meibomian gland dysfunction (MGD) and will evaluate the correlation between signs and symptoms of MGD. No investigational drug will be administered in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Meibum Expression | Meibum expression as per protocol. No investigational drug is administered in this study. |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2013-11-08
- Last updated
- 2014-08-15
Locations
2 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT01979887. Inclusion in this directory is not an endorsement.